Sections
Title | Starting Page | Number of Pages |
---|
Overview | 1 | 1 |
Business model | 1 | 1 |
Cash receipts growth demonstrates earnings momentum | 1 | 1 |
Base-case DCF valuation is $0.31/share, fully diluted | 1 | 1 |
Table/Chart: Historical earnings and RaaS’ forecasts (in $A unless otherwise stated) | 1 | 1 |
Table/Chart: Share Details | 1 | 1 |
Graph: Share Performance (12 months) | 1 | 1 |
Upside Case | 1 | 1 |
Downside Case | 1 | 1 |
Catalysts | 1 | 1 |
Table/Chart: Board of Directors | 1 | 1 |
Company Interview | 1 | 1 |
Disclosure | 1 | 1 |
Q2 FY25 Results Discussion | 2 | 1 |
Graph: Exhibit 1: Quarterly cash receipts Q1 FY18-Q2 FY25 | 2 | 1 |
Table/Chart: Exhibit 2: Q2 FY25 versus Q2 FY24, Q1 FY25 and RaaS forecasts for Q2 FY25 (in A $m unless otherwise stated) | 2 | 1 |
Key points from market sector update | 3 | 1 |
H1 FY25 Cash Flow Discussion | 3 | 1 |
Table/Chart: Exhibit 3: H1 FY25 versus H1 FY24 and RaaS forecast (in A $m unless otherwise stated) | 4 | 1 |
DCF Valuation Remains Unchanged | 4 | 1 |
Table/Chart: Exhibit 4: DCF valuation | 4 | 1 |
Table/Chart: Exhibit 5: Financial Summary | 5 | 1 |
FINANCIAL SERVICES GUIDE | 6 | 1 |
RaaS Research Group Pty Ltd | 6 | 1 |
Corporate Authorised Representative, number 1248415, of | 6 | 1 |
About Us | 6 | 1 |
Our general advice service | 6 | 1 |
How are we paid? | 6 | 1 |
Associations and Relationships | 6 | 1 |
Complaints | 6 | 1 |
Professional Indemnity Insurance | 6 | 1 |
Disclosure | 7 | 1 |